Piotr Popik

Q: What Schools Are Affiliated With Piotr Popik

Piotr Popik is affiliated with the following schools: Medical University of Warsaw, University of Warsaw, Jagiellonian University

Piotr Popik's AcademicInfluence.com Rankings

Piotr Popik

Biology

#11892

World Rank

#15325

Historical Rank

Neuroscience

#2335

World Rank

#2399

Historical Rank

biology Degrees

Download Badge

Biology

Piotr Popik's Degrees

PhD Neuropsychopharmacology University of Warsaw
Doctorate Medicine Medical University of Warsaw

Why Is Piotr Popik Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Piotr Popik is a Polish neuropsychopharmacologist specializing in the research of drugs that affect the brain and conditions such as depression, drug addiction, cognitive and social disturbances as well as animal emotions and communication.

(See a Problem?)

Piotr Popik's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Glutamate-based antidepressants: 20 years on. (2009) (358)
Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. (1996) (340)
Adenosine A3 receptor stimulation and cerebral ischemia. (1994) (255)
Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. (1994) (244)
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests (2007) (186)
Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. (2009) (177)
Low doses of oxytocin facilitate social recognition in rats (2005) (166)
100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug. (1995) (162)
Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715) (1995) (138)
Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor. (2003) (136)
Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist (2002) (125)
Laughing Rats Are Optimistic (2012) (125)
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans (2001) (120)
Oxytocin but not vasopressin facilities social recognition following injection into the medial preoptic area of the rat brain (1991) (116)
Trait Pessimism Predicts Vulnerability to Stress-Induced Anhedonia in Rats (2013) (113)
In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists. (2000) (110)
The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence (1996) (109)
Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. (1997) (108)
Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. (2010) (106)
NMDA antagonist properties of the putative antiaddictive drug, ibogaine. (1995) (103)
Neurohypophyseal peptides and social recognition in rats. (1998) (103)
Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor. (2006) (102)
Lack of persistent effects of ketamine in rodent models of depression (2008) (99)
Chronic psychosocial stress makes rats more ‘pessimistic’ in the ambiguous-cue interpretation paradigm (2013) (98)
Neurohypophyseal hormone receptors in the septum are implicated in social recognition in the rat. (1992) (91)
"Broad spectrum" antidepressants: is more better for the treatment of depression? (2003) (90)
Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice (2006) (87)
Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats (2013) (85)
Nicotine and nicotinic receptor antagonists potentiate the antidepressant‐like effects of imipramine and citalopram (2003) (82)
Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants (2007) (79)
Opposite action of oxytocin and its peptide antagonists on social memory in rats (1991) (76)
Effects of a Positive Allosteric Modulator of Group II Metabotropic Glutamate Receptors, LY487379, on Cognitive Flexibility and Impulsive-Like Responding in Rats (2010) (73)
Inhibition of reinforcing effects of morphine and naloxone: precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists (1998) (73)
Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats (2010) (71)
Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward (1999) (71)
Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats (2015) (70)
Cooperative behavior of laboratory rats (Rattus norvegicus) in an instrumental task. (2011) (70)
Reinstatement of Morphine-Conditioned Reward is Blocked by Memantine (2006) (67)
Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors. (1998) (66)
Characterization of the Antinociceptive Actions of Bicifadine in Models of Acute, Persistent, and Chronic Pain (2007) (59)
Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence (2000) (57)
Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice (2002) (57)
Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor (2015) (56)
The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice (2010) (56)
Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice (2003) (56)
Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice (2000) (55)
The effects of acute pharmacological stimulation of the 5-HT, NA and DA systems on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm (2014) (54)
Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants (2011) (54)
Colostrinin, a Polypeptide Isolated From Early Milk, Facilitates Learning and Memory in Rats (1999) (53)
Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease. (2016) (49)
RECOGNITION CUE IN THE RAT'S SOCIAL MEMORY PARADIGM (1991) (49)
Pharmacological Profile of the “Triple” Monoamine Neurotransmitter Uptake Inhibitor, DOV 102,677 (2006) (48)
Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders (2000) (48)
A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice (2005) (47)
Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. (2001) (47)
Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats (2016) (46)
Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice (2000) (46)
Effects of optimism on motivation in rats (2015) (45)
Facilitation and attenuation of social recognition in rats by different oxytocin-related peptides. (1996) (44)
Neuropeptides related to [Arg8]vasopressin facilitates social recognition in rats (1991) (44)
Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats (2011) (44)
Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors. (1996) (43)
Chapter 3 - Pharmacology of Ibogaine and Ibogaine-Related Alkaloids (1999) (43)
The Anxioselective Agent 7-(2-Chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) Is More Efficacious Than Diazepam at Enhancing GABA-Gated Currents at α1 Subunit-Containing GABAA Receptors (2006) (42)
The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors (2016) (42)
Morphine Tolerance and Reward but not Expression of Morphine Dependence are Inhibited by the Selective Glutamate Carboxypeptidase II (GCP II, NAALADase) Inhibitor, 2-PMPA (2003) (41)
Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test. (2013) (40)
Memantine reduces consumption of highly palatable food in a rat model of binge eating (2010) (38)
Long-term facilitation of social recognition in rats by vasopressin related peptides: a structure-activity study. (1992) (38)
Opiate withdrawal with dextromethorphan. (1997) (37)
3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats (2017) (37)
N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties. (2016) (36)
Social transmission of flavored tea preferences: facilitation by a vasopressin analog and oxytocin. (1993) (35)
Amisulpride promotes cognitive flexibility in rats: The role of 5-HT7 receptors (2013) (34)
Novel non-sulfonamide 5-HT6 receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties. (2018) (34)
Human opiorphin: The lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice (2010) (34)
Increased depressive-like traits in an animal model of premenstrual irritability (2007) (33)
The effects of acute and repeated administration of ketamine on attentional performance in the five-choice serial reaction time task in rats (2014) (33)
Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects. (2018) (32)
Preclinical pharmacology of citalopram. (1999) (31)
GlycineB antagonists as potential therapeutic agents (1998) (31)
Ketamine prevents stress-induced cognitive inflexibility in rats (2014) (31)
The effects of cocaine and mazindol on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm (2014) (31)
The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats (2013) (30)
Enhancement of Antidepressant-Like Effects but Not Brain-Derived Neurotrophic Factor mRNA Expression by the Novel N-Methyl-d-aspartate Receptor Antagonist Neramexane in Mice (2006) (30)
Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test. (1999) (30)
The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia (2016) (30)
Pro‐cognitive activity in rats of 3‐furan‐2‐yl‐N‐p‐tolyl‐acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor (2015) (29)
The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex (1994) (29)
High-frequency ultrasonic vocalizations in rats in response to tickling: The effects of restraint stress (2012) (26)
Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance (2005) (25)
The continued need for animals to advance brain research (2021) (25)
Introduction to the EQIPD quality system (2020) (25)
Trait “pessimism” is associated with increased sensitivity to negative feedback in rats (2016) (25)
Acute administration of lithium, but not valproate, modulates cognitive judgment bias in rats (2014) (24)
Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner (2011) (23)
Nicotine produces antidepressant-like actions: Behavioral and neurochemical evidence. (2005) (23)
Facilitation of memory retrieval by the "anti-addictive" alkaloid, ibogaine. (1996) (23)
Molecular features associated with polyamine modulation of NMDA receptors. (1998) (22)
1-Aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats (2014) (22)
Effects of optimism on gambling in the rat slot machine task (2016) (22)
Cognitive judgment bias in the psychostimulant-induced model of mania in rats (2014) (21)
The effects of NMDA receptor antagonists on acute morphine antinociception in mice (2002) (21)
Ca2+ antagonists effect an antidepressant-like adaptation of the NMDA receptor complex. (1993) (20)
Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats (2019) (20)
Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors (2015) (20)
Dual 5-HT6 and D3 Receptor Antagonists in a Group of 1 H-Pyrrolo[3,2- c]quinolines with Neuroprotective and Procognitive Activity. (2019) (19)
Effects of the selective 5-HT7 receptor antagonist SB-269970 on premature responding in the five-choice serial reaction time test in rats (2015) (19)
A Novel Dopamine Transporter Inhibitor CE-123 Improves Cognitive Flexibility and Maintains Impulsivity in Healthy Male Rats (2017) (19)
Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats (2013) (19)
Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties. (2019) (19)
Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents (2017) (19)
Retrieval associated cholinergic activity and its inhibition by memory updating. (1994) (18)
[3H]1-aminocyclopropanecarboxylic acid, a novel probe for strychnine- insensitive glycine receptors. (1995) (17)
A complete analysis of NMDA receptor subunits in periaqueductal grey and ventromedial medulla of morphine tolerant mice. (2007) (17)
Cognitive effects of Colostral-Val nonapeptide in aged rats (2001) (17)
Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrins (2018) (16)
Serotonin transporter deficiency alters socioemotional ultrasonic communication in rats (2019) (16)
2-Aminoimidazole-based antagonists of the 5-HT6 receptor - A new concept in aminergic GPCR ligand design. (2019) (16)
The effect of electroconvulsive shock and nifedipine on spatial learning and memory in rats (1994) (15)
Valproic acid exposure impairs ultrasonic communication in infant, adolescent and adult rats (2020) (15)
Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of rats (2019) (15)
The effects of PDE10 inhibition on attentional set-shifting do not depend on the activation of dopamine D1 receptors (2016) (14)
Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies (2020) (14)
Anandamide mediates cognitive judgement bias in rats (2016) (14)
N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile. (2016) (14)
Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile. (2017) (14)
Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α7-nicotinic acetylcholine receptors (2018) (14)
An Animal Model of Premenstrual Dysphoric Disorder Sensitive to Antidepressants (2009) (13)
Antidepressant-like activity of venlafaxine and clonidine in mice exposed to single prolonged stress – A model of post-traumatic stress disorder. Pharmacodynamic and molecular docking studies (2017) (13)
Dopamine D2/D3 receptor agonists attenuate PTSD-like symptoms in mice exposed to single prolonged stress (2019) (13)
Inhibition of the glucocorticoid synthesis reverses stress-induced decrease in rat's 50-kHz ultrasonic vocalizations (2014) (13)
2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice (2005) (13)
Effects of prenatal exposure to valproic acid or poly(I:C) on ultrasonic vocalizations in rat pups: The role of social cues (2020) (12)
Antidepressants alleviate the impact of reinforcer downshift (2009) (12)
Hypersensitivity to amphetamine's psychomotor and reinforcing effects in serotonin transporter knockout rats: Glutamate in the nucleus accumbens (2020) (12)
Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test (2015) (12)
Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats (2017) (12)
Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States. (2021) (11)
Dopamine induces an optimism bias in rats—Pharmacological proof for the translational validity of the ambiguous-cue interpretation test (2016) (11)
Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia (2017) (11)
A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties. (2020) (11)
Neurochemical modulation of stress-induced cognitive inflexibility in a rat model of an attentional set-shifting task. (2013) (11)
Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice. (2008) (10)
Arylsulfonamide derivatives of (aryloxy)ethylpiperidines as selective 5-HT7 receptor antagonists and their psychotropic properties (2015) (10)
The Effect of Maternal Immune Activation on Social Play-Induced Ultrasonic Vocalization in Rats (2021) (10)
Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats (2020) (9)
A partial agonist at strychnine-insensitive glycine sites facilitates spatial learning in aged rats. (1999) (9)
The effect of ageing and cerebral serotonin deficit on the activity of cytochrome P450 2D (CYP2D) in the brain and liver of male rats (2020) (9)
Strain differences in changes in some parameters of cerebral cortical adrenergic system following chronic imipramine administration to rats. (1991) (9)
Attentional Set‐Shifting Paradigm in the Rat (2015) (9)
The effects of a 5-HT 5 A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia (2016) (8)
1-Methyl-1,2,3,4-tetrahydroisoquinoline attenuates ethanol, cocaine and morphine addiction in behavioral models: neurochemical correlates (2005) (8)
Distinct cognitive and discriminative stimulus effects of ketamine enantiomers in rats (2020) (8)
Chapter 12 Anxiogenic action of ibogaine (2001) (8)
R-(−)-ketamine modifies behavioral effects of morphine predicting efficacy as a novel therapy for opioid use disorder1 (2020) (8)
Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties (2021) (7)
Similar action of imipramine and arginine-vasopressin in the social interaction test. (1993) (7)
Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats (2020) (7)
Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats (2022) (7)
Stability and variability of locomotor responses of laboratory rodents. II. Native exploratory and basal locomotor activity of Wistar rats. (1987) (6)
Stability and variability of locomotor responses of laboratory rodents. III. Effect of environmental factors and lack of catecholamine receptor correlates. (1988) (5)
Morphine-induced place preference affects mRNA expression of G protein α subunits in rat brain. (2012) (5)
2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity (2021) (5)
Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats (2019) (5)
Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats (2021) (5)
Social memory and neurohypophyseal hormones (1993) (5)
N-(4-Arylpiperazinoalkyl)acetamide derivatives of 1,3- and 3,7-dimethyl-1H-purine-2,6(3H,7H)-diones and their 5-HT6, 5-HT7, and D2 receptors affinity (2015) (5)
One-Step Preparation of [2,3-3H]1-Aminocyclopropanecarboxylic Acid: A Useful Ligand for Strychnine-Insensitive Glycine Receptors (1994) (4)
Phencyclidine disturbs relational memory in the transitive inference task (2011) (4)
Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines. (2022) (4)
Conditioned rewarding effects of morphine and methadone in mice pre-exposed to cocaine. (2013) (4)
Anxiogenic action of ibogaine. (2001) (3)
Electroconvulsive shock-induced impairment of spatial learning is aggravated by nifedipine. (1993) (3)
Effects of ketamine and tiagabine in mice exposed to single prolonged stress protocol, a mouse model of posttraumatic stress disorder (2018) (2)
Cognitive judgment bias in the psychostimulant-induced model of mania in rats (2014) (2)
Sex, Pramipexole and Tiagabine Affect Behavioral and Hormonal Response to Traumatic Stress in a Mouse Model of PTSD (2021) (2)
Behavioral effects of buspirone in a mouse model of posttraumatic stress disorder (2019) (2)
Rapid tolerance to behavioral effects of ethanol in rats: Prevention by R-(−)-ketamine (2021) (2)
N -Methyl-d-Aspartate (NMDA) Antagonists for the Treatment of Depression (2010) (2)
Colostrinin and colostrinin-derived nonapeptide (colostral-val nonapeptide, CVNP) facilitate learning and memory in rats. (2001) (2)
Further dissociation between the memory-facilitating effects of low and memory-attenuating effects of high doses of oxytocin. A structure-activity study (1992) (1)
1-Aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats (2014) (1)
Author response: Introduction to the EQIPD quality system (2021) (1)
Repeated treatment with alpha 7 nicotinic acetylcholine receptor ligands enhances cognitive processes and stimulates Erk1/2 and Arc genes in rats (2021) (1)
[Contemporary methods in pharmacotherapy in the opiate dependent treatment]. (2000) (1)
Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats (2013) (1)
Effects of ketamine optical isomers, fluoxetine and naloxone on timing in differential reinforcement of low-rate response (DRL) 72-s task in rats (2022) (1)
Pyrroloquinoline derivatives as 5-HT6, method of preparation and use thereof (2013) (0)
B75 EFFECT OF 5-HT3 RECEPTOR ANTAGONIST MDL 72222 ON BEHAVIORS INDUCED BY KETAMINE IN RATS AND MICE (2005) (0)
P.2.024 The effects of positive allosteric modulators of α7 nicotinic receptors on rats' performance in the odour span test (2013) (0)
Activation of Alpha 7 nicotinic acetylcholine receptors against cognitive and sensorimotor gating deficits in animal model of schizophrenia (2015) (0)
Clinically available NMDA antagonist, memantine attenuates analgesic morphine tolerance in a mouse tail flick test (1999) (0)
In search of the anxiolytic effects of nicotinic receptor ligands (2006) (0)
P.0906 The effects of aging and cerebral serotonin deficiency on brain and liver cytochrome P450 2D in female rats – sex differences (2021) (0)
Polish-French scientific conference: Alzheimer's disease and neurodegenerative disorders: what challenges for tomorrow? (2016) (0)
P.0847 Acute genetic depletion of brain serotonin contributes to dominant behaviour and changes in ultrasonic vocalisation in rats (2021) (0)
Retraction notice to “Dopamine induces an optimism bias in rats – Pharmacological proof for the translational validity of the ambiguous-cue interpretation test” [Behav. Brain Res. 297 (2016) 84–90] (2016) (0)
Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents (2017) (0)
Effects of genetic deficiency of tryptophan hydroxylase 2 on attentional processes in the five choice serial reaction time task in rats (2018) (0)
Positive allosteric modulation of nicotinic receptors: a new hope to treat cognitive deficits? (2014) (0)
Pro-cognitive effects of a AHN-208, 5-HT6 receptor antagonist, in the novel object recognition test in rats (2018) (0)
Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats (2011) (0)
The Ibogaine Dossier. Pharmacology of Ibogaine (2019) (0)
P.1.g.006 A selective blockade of 5-HT7 receptors promotes cognitive flexibility in rats (2011) (0)
Rats that ‘gamble’ demonstrate impaired cognitive flexibility in the attentional set shifting task (2014) (0)
P69 1-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE (1METIQ) INHIBITS CONDITIONED MORPHINE REWARD IN MICE (2004) (0)
Maternal immune activation affects socio-communicative behavior in adult rats (2023) (0)
Modification of Conditioned Reward by N -Methyl- d -aspartate Receptor Antagonists (2002) (0)
Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats (2019) (0)
Neurochemical correlates of memory retrieval cholinergic and glutamatergic interaction (1995) (0)
Acute administration of lithium, but not valproate, modulates cognitive judgment bias in rats (2014) (0)
Trait “pessimism” is associated with increased sensitivity to negative feedback in rats (2016) (0)
Retraction notice to “Dopamine induces an optimism bias in rats—Pharmacological proof for the translational validity of the ambiguous-cue interpretation test” [Behav. Brain Res. 297 (2016) 84–90] (2016) (0)
Procognitive activity in rats of 3-furan-2-yl-Np-tolyl-acrylamide , a positive allosteric modulator of the α 7 nicotinic acetylcholine receptor (2015) (0)
ffects of the selective 5-HT 7 receptor antagonist SB-269970 on remature responding in the five-choice serial reaction time test in ats (2015) (0)
A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects (2022) (0)
The antagonists of metabotropic glutamate receptors produce anxiolytic-like effects and attenuate morphine abstinence symptoms in animals (1996) (0)
P.517 mGluR2/3 receptor antagonist LY341495 attenuates PTSD symptoms mimicked in a mouse model of single-prolonged stress (2019) (0)
Activation of the alpha4 beta2 nicotinic acetylcholine receptor facilitates set-shifting performance in rats (2018) (0)
Correction to: Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats (2020) (0)
P.2.023 The antagonist of 5-HT7 receptors, SB-269970, and amisulpride both reverse ketamine-induced cognitive inflexibility in rats (2013) (0)
P.1.d.002 The effect of chlordiazepoxide on reward reduction-induced decrease of operant performance (2008) (0)
Pharmacological modulation of memory (2011) (0)
Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrins (2018) (0)
SB 742,457, a 5-HT6 receptor antagonist, reverses cognitive impairment induced by scopolamine in the Novel Object Recognition Test in rats (2014) (0)
The effects of ligands of the alpha7 nicotinic acetylcholine receptors on memory and social behaviour in the neurodevelopmental model of schizophrenia (2018) (0)
Effects of prenatal exposure to methylazoxymethanol acetate on juvenile social play behavior and ultrasonic communication in male and female rats (2018) (0)
Nicotine potentiates imipramine-induced effects on catecholamine metabolism: possible relation to antidepressant activity. (2006) (0)

This paper list is powered by the following services:

Other Resources About Piotr Popik

en.wikipedia.org

What Schools Are Affiliated With Piotr Popik?

Piotr Popik is affiliated with the following schools:

Piotr Popik's Academic­Influence.com Rankings